Torchmark CEO Discusses Q2 Results - Earnings Call Transcript

Torchmark Corporation (TMK)

Q2 2012 Earnings Call

July 26, 2012 11:00 am ET


Mark McAndrew - Executive Chairman of the Board

Gary Coleman - Co-Chief Executive Officer

Larry Hutchison - Co-Chief Executive Officer

Frank Svoboda - Chief Financial Officer


Vincent Lu - Morningstar

Jeff Schuman - KBW

Chris Giovanni - Goldman Sachs

Sarah DeWitt - Barclays

Randy Binner - FBR

Paul Sarran - Evercore Partners

Mark Hughes - SunTrust

Jimmy Bhullar - JPMorgan

John Nadel - Sterne Agee

Steven Schwartz - Raymond James & Associates

Ed Forun - Nomura



Good day and welcome to Torchmark Corporation's second quarter 2012 earnings release conference call. Today's call is being recorded.

For opening remarks and introductions, I would like to turn the call over to Mike Majors, Vice President of Investor Relations of Torchmark Corporation. Please go ahead.

Mike Majors

Thank you. Good morning, everyone. Joining me today are Gary Coleman, and Larry Hutchison, our Co-CEOs. Mark McAndrew, our Executive Chairman. Frank Svoboda, our Chief Financial Officer, and Brian Mitchell, our General Counsel.

Some of our comments or answers to your questions may contain forward-looking statements that are provided for general guidance purposes only. Accordingly, please refer to our 2011 10-K and any subsequent Forms 10-Q on file with the SEC.

I'll now turn the call over to Gary Coleman.

Gary Coleman

Thanks, Mike. Good morning, everyone. Net operating income for the second quarter was $127 million, or $1.30 per share, a per share increase of 19% from a year ago. Net income for the quarter was $129 million or $1.32 per share, a 4% increase on a per share basis.

If you liked this article you might like

The Stock Market Is on Fire, Especially in These Sectors: Market Recon

Market Recon: The Banks Trade Will Become a Yield Curve Watch

Market Recon: Forget About a Rate Rise for Now

Turn to Insurers for Some Portfolio Insurance

Analysts' Actions -- Chipotle, Nvidia, Qualcomm, Teva and More